The weed wire

New dates for the release of the information have not yet been set

Canadian cannabis producer says move will help cut costs

Company reports fifth consecutive profitable quarter as Health Canada green lights Delta 2 facility

Cova's point-of-sale software is used by over half of Canadian retailers, company says

'Office centricity' might be over for some, but majority of cannabis industry can't work remotely

US$40M acquisition of Reliva gives Aurora the No. 2 US CBD brand by market share

The government of Nunavut will start taking licence applications June 1 for its first physical weed shops

The clear leader of Florida's highly competitive medical market is one of the most profitable in the cannabis space

Company says it will have 100 dispensaries operating in 22 US states by end of year

Rising revenues and increased efficiencies boost company stock

The 44,000 kilograms of hemp biomass will be processed at the Sherbrooke, QC, facility.

A decrease in business-to-business sales was offset by increase in direct-to-consumer sales, company says

While positive cash flow remains rare in the cannabis industry, Aleafia reported it in two straight quarters

The industry giant will soon have its third and fourth infused beverage products in Canada's weed market

The acquired company has all the licensing to import and distribute medical cannabis throughout Germany, according to a statement

Company said it had to grapple with reducing its 1,443-member workforce by 10% in February and restructure its operations

Company is testing similar cannabis drug to see if it can treat symptoms of COVID-19 in humans

20K new members have joined since stay-at-home orders came into effect in March, company says

Drug sales spiked 25 per cent during first 3 months of the year

CEO Irwin Simon told BNN Bloomberg it's laying off a dozen staff including its chief marketing officer

CaaMTech will be researching synthetic tryptamine-based compounds as part of a cooperative R&D program

Deal brings newly-launched topical to national medical market

The highly potent but non psychoactive compound has anti-tumour properties, company says

Amid the pandemic, IIPR says it's deferred rents from 3 of its tenants

Data firm forecasts a looming global recession and Illinois' surging legal weed market will spur US cannabis reform

Investment deal comes days after parent company Canopy Growth got a $245 million injection from its largest shareholder

The Cannabis Legalisation and Control bill will need 50% support to pass during September referendum

Class action lawsuit unable to prove trace amounts of pesticides made users sick

Loss comes in part from impairment and restructuring charges

Cannabis NB predicts that pantry loading during COVID-19 helped boost March sales

Company revenue rose 26% year-over-year to US$75 million

The company has laid off an additional 200 workers in Canadian, UK and US operations

The benefits of 'inhalable aromatherapy' has driven the popularity of alternative vapes, says Research and Markets

The latest revelation follows reports of a leaked management buyout plan called Project Greta

The company is expanding its strategy of obtaining rare drug designations for cannabis-based drugs during the pandemic

The company said it's now producing over a million units per week

New Zealand could legalize recreational cannabis this September via referendum

The Cannabis Act says characters can't be used to promote cannabis products

Canadian cannabis 2.0 sales are on the rise and other weekly insights from the data firm

The latest in a series of aggressive cutbacks spearheaded by new CEO David Klein